Global Allergy Immunotherapy Market By Type [allergic rhinitis, allergic asthma, food allergy, drug allergy and others],By Treatment [subcutaneous immunotherapy and sublingual immunotherapy], By Distribution Channel[Hospital pharmacy, Retail pharmacy and Online pharmacy]: Market Research Report 2021 : Covid 19 Impact Outlook, Regional Analysis, Competitive Landscape, Growth Prospects & Forecast 2020-2026
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. List of Abbreviations
2. Executive Summary
3. Market Overview
- 3.1. Market Definition
- 3.2. Market Scope
- 3.3. Market Drivers
- 3.4. Market Restraints
- 3.5. Market Opportunities and Trends
- 3.6. Porter’s five force analysis
- 3.7. SWOT Analysis
- 3.8. PEST Analysis
- 3.9. Patent Analysis
- 3.10. Impact of COVID 19 on Global Allergy Immunotherapy Market
4. Allergy Immunotherapy Market, By Type, Market Size and Forecast 2016 -2026 (USD Billion)
- 4.1. Global Allergy Immunotherapy Market By Type, 2016 -2026 (USD Billion)
- 4.1.1. Global Allergy Immunotherapy Market By allergic rhinitis
- 4.1.2. Global Allergy Immunotherapy Market By allergic asthma
- 4.1.3. Global Allergy Immunotherapy Market By food allergy
- 4.1.4. Global Allergy Immunotherapy Market By drug allergy
- 4.1.5. Global Allergy Immunotherapy Market By others
- 4.2. Global Allergy Immunotherapy Market By Type Share, 2016 -2026 (%)
5. Allergy Immunotherapy Market, By Distribution Channel, Market Size and Forecast 2016 -2026 (USD Billion)
- 5.1. Global Allergy Immunotherapy Market By Distribution Channel, 2016 -2026 (USD Billion)
- 5.1.1. Global Allergy Immunotherapy Market By Hospital pharmacy
- 5.1.2. Global Allergy Immunotherapy Market By Retail pharmacy
- 5.1.3. Global Allergy Immunotherapy Market By Online pharmacy
- 5.2. Global Allergy Immunotherapy Market By Distribution Channel Share, 2016 -2026 (%)
6. Allergy Immunotherapy Market, By Treatment, Market Size and Forecast 2016 -2026 (USD Billion)
- 6.1. Global Allergy Immunotherapy Market By Treatment, 2016 -2026 (USD Billion)
- 6.1.1. Global Allergy Immunotherapy Market By subcutaneous immunotherapy
- 6.1.2. Global Allergy Immunotherapy Market By sublingual immunotherapy
- 6.2. Global Allergy Immunotherapy Market By Treatment Share, 2016 -2026 (%)
7. Allergy Immunotherapy Market, By Region Market Size and Forecast 2016 -2026
- 7.1. NORTH AMERICA
- 7.1.1. Key Findings
- 7.1.2. Impact of COVID 19
- 7.1.3. Key market trends, growth factors and opportunities
- 7.1.4. North America Allergy Immunotherapy Market by Country 2016 -2026 (USD Billion)
- 7.1.5. North America Allergy Immunotherapy Market By Type 2016 -2026 (USD Billion)
- 7.1.6. North America Allergy Immunotherapy Market By Treatment 2016 -2026 (USD Billion)
- 7.1.7. North America Allergy Immunotherapy Market By Distribution Channel 2016 -2026 (USD Billion)
- 7.2. EUROPE
- 7.2.1. Key Findings
- 7.2.2. Impact of COVID 19
- 7.2.3. Key market trends, growth factors and opportunities
- 7.2.4. Europe Allergy Immunotherapy Market by Country 2016 -2026 (USD Billion)
- 7.2.5. Europe Allergy Immunotherapy Market By Type 2016 -2026 (USD Billion)
- 7.2.6. Europe Allergy Immunotherapy Market By Treatment 2016 -2026 (USD Billion)
- 7.2.7. Europe Allergy Immunotherapy Market By Distribution Channel 2016 -2026 (USD Billion)
- 7.3. ASIA PACIFIC
- 7.3.1. Key Findings
- 7.3.2. Impact of COVID 19
- 7.3.3. Key market trends, growth factors and opportunities
- 7.3.4. Asia Pacific Allergy Immunotherapy Market by Country 2016 -2026 (USD Billion)
- 7.3.5. Asia Pacific Allergy Immunotherapy Market By Type 2016 -2026 (USD Billion)
- 7.3.6. Asia Pacific Allergy Immunotherapy Market By Treatment 2016 -2026 (USD Billion)
- 7.3.7. Asia Pacific Allergy Immunotherapy Market By Distribution Channel 2016 -2026 (USD Billion)
- 7.4. LATIN AMERICA
- 7.4.1. Key Findings
- 7.4.2. Impact of COVID 19
- 7.4.3. Key market trends, growth factors and opportunities
- 7.4.4. Latin America Allergy Immunotherapy Market by Country 2016 -2026 (USD Billion)
- 7.4.5. Latin America Allergy Immunotherapy Market By Type 2016 -2026 (USD Billion)
- 7.4.6. Latin America Allergy Immunotherapy Market By Treatment 2016 -2026 (USD Billion)
- 7.4.7. Latin America Allergy Immunotherapy Market By Distribution Channel 2016 -2026 (USD Billion)
- 7.5. MIDDLE EAST AND AFRICA
- 7.5.1. Key Findings
- 7.5.2. Impact of COVID 19
- 7.5.3. Key market trends, growth factors and opportunities
- 7.5.4. Middle East and Africa Allergy Immunotherapy Market by Country 2016 -2026 (USD Billion)
- 7.5.5. Middle East and Africa Allergy Immunotherapy Market By Type 2016 -2026 (USD Billion)
- 7.5.6. Middle East and Africa Allergy Immunotherapy Market By Treatment 2016 -2026 (USD Billion)
- 7.5.7. Middle East and Africa Allergy Immunotherapy Market By Distribution Channel 2016 -2026 (USD Billion)
8. Competitive Landscape Analysis
- 8.1. Global Allergy Immunotherapy Market Company Revenue, (USD Billion), 2016-2019
- 8.2. Global Allergy Immunotherapy Market Company Share, (%), 2016-2019
9. Company Profiles
- 9.1. Biomay AG
- 9.2. DBV Technologies.
- 9.3. Aimmune Therapeutics Inc.
- 9.4. Leti Pharma
- 9.5. HAL Allergy Group
- 9.6. ALK-Abello A/S
- 9.7. Allergopharma
- 9.8. Jubilant Life Sciences Ltd.
- 9.9. Merck KGaA
- 9.10. Stallergenes Greer
- 9.11. Others
10. Appendix
11. List of Tables
12. List of Figures
Global Allergy Immunotherapy Market 2020 By Type [allergic rhinitis, allergic asthma, food allergy, drug allergy and others],By Treatment [subcutaneous immunotherapy and sublingual immunotherapy], By Distribution Channel[Hospital pharmacy, Retail pharmacy and Online pharmacy]: Global Forecast to 2026 and COVID-19 Impact Outlook
Global Allergy Immunotherapy Market is valued at 1.81 USD Billion in 2019 and expected to reach USD 3.61 Billion by 2026 with the CAGR of 10.34% over the forecast period.
Scope of the report
This report analyses the global market for Allergy Immunotherapy. The report will enable the user to understand and gain insights into the current and forecast market situation. The market is comprehensively analyzed by geography to give complete information on the global scenario. The qualitative and quantitative data provided in this study can help user understand which market segments, regions are expected to grow at higher rates, factors affecting the market and key opportunity areas. The report also includes competitive landscape of key players in the industry along with emerging trends in the market.
Key Players
Biomay AG,DBV Technologies.,Aimmune Therapeutics Inc.,Leti Pharma,HAL Allergy Group,ALK-Abello A/S,Allergopharma,Jubilant Life Sciences Ltd.,Merck KGaA,Stallergenes Greer and others
Above mentioned companies were scrutinized to assess competitive landscape of global Allergy Immunotherapy market. Report provides company profiles of each player. Each profile include company product portfolio,business overview, company governance, company financials, business strategies, manufacturing locations and production facilities, company sale, recent developments and strategic collaborations & partnerships, new product launch, company segments, application diversification and company strength and weakness analysis.
Review period:
(2016-2026)
Historic Period: 2016 to 2019
Forecast Period: 2020 to 2026
Base Year: 2019
Unit: USD Billion
This Allergy Immunotherapy market report provides insights on new trade regulations, import export analysis, industry value chain analysis, market size, consumption, production analysis, capacity analysis, regional and segment market share, product launches, product pipeline analysis, impact of Covid-19 on supply chain, key regions, untapped markets, patent analysis, product approvals, continuous innovations and developments in the market.
Regions
• North America: U.S., Canada and Rest of North America
• Europe: UK, France, Germany, Italy, Spain and Rest of Europe
• Asia Pacific: China, Japan, India, Australia, Southeast Asia and Rest of Asia Pacific
• Latin America: Brazil, Mexico, Argentina and Rest of Latin America
• Middle East and Africa: Gulf Countries, Israel, Africa and Rest of Middle East and Africa
Market Segmentation
• Type
o allergic rhinitis
o allergic asthma
o food allergy
o drug allergy
o others
• Treatment
o subcutaneous immunotherapy
o sublingual immunotherapy
• Distribution Channel
o Hospital pharmacy
o Retail pharmacy
o Online pharmacy
Report Coverage
• An overview of the global Allergy Immunotherapy market
• In depth analysis of market dynamics and major factors such as drivers, restraints, opportunities and trends influencing the global market
• Global Allergy Immunotherapy market revenue data historic and forecast analysis (2016 to 2026)
• Characterization and quantification of the market segments for Allergy Immunotherapy market
• Market share analysis of key market participants and their competitive landscape
Important Questions Answered by Global Allergy Immunotherapy Market Report
• What is the impact of COVID 19 epidemic on the global Allergy Immunotherapy market?
• Which is mostly affected region, country?
• Which is the current largest and fastest-growing region?
• What is the market size and growth rate of the global Allergy Immunotherapy market?
• What are current factors affecting the growth of market?
• What are Key trends and opportunity areas?
• Within Allergy Immunotherapy market, which segments are fastest growing & emerging strongly? What are the drivers and restraints for each segment? What are vendor competencies by segment?
• What are the major strategies adopted by leading market companies?
• What are company challenges and essential success factors by marketsegment?
• How company offerings and supply chain capabilitiesare shifting to meetemerging market needs?